These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 30779214)
1. The association of indoxyl sulfate with fibroblast growth factor-23 in cats with chronic kidney disease. Liao YL; Chou CC; Lee YJ J Vet Intern Med; 2019 Mar; 33(2):686-693. PubMed ID: 30779214 [TBL] [Abstract][Full Text] [Related]
3. Plasma indoxyl sulfate concentration predicts progression of chronic kidney disease in dogs and cats. Chen CN; Chou CC; Tsai PSJ; Lee YJ Vet J; 2018 Feb; 232():33-39. PubMed ID: 29428089 [TBL] [Abstract][Full Text] [Related]
4. The effect of feeding a renal diet on plasma fibroblast growth factor 23 concentrations in cats with stable azotemic chronic kidney disease. Geddes RF; Elliott J; Syme HM J Vet Intern Med; 2013; 27(6):1354-61. PubMed ID: 24010686 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease. Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 (FGF-23) concentrations in cats with early nonazotemic chronic kidney disease (CKD) and in healthy geriatric cats. Finch NC; Geddes RF; Syme HM; Elliott J J Vet Intern Med; 2013; 27(2):227-33. PubMed ID: 23363336 [TBL] [Abstract][Full Text] [Related]
7. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease. Lin J; Lin L; Chen S; Yu L; Chen S; Xia Z J Vet Diagn Invest; 2021 Mar; 33(2):288-293. PubMed ID: 33543676 [TBL] [Abstract][Full Text] [Related]
8. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease. Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098 [TBL] [Abstract][Full Text] [Related]
9. Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease. Geddes RF; Elliott J; Syme HM J Vet Intern Med; 2015; 29(6):1494-501. PubMed ID: 26403212 [TBL] [Abstract][Full Text] [Related]
10. Effect of aluminum hydroxide on serum phosphate and fibroblast growth factor 23 concentrations in young adult cats with surgically induced chronic kidney disease. Beita KG; Lourenço BN; Rehagen M; Schmiedt CW Am J Vet Res; 2024 Oct; 85(10):. PubMed ID: 39137806 [TBL] [Abstract][Full Text] [Related]
11. Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review. Summers S; Michael HT; Szlosek D; Mack R J Feline Med Surg; 2024 Apr; 26(4):1098612X241234984. PubMed ID: 38682929 [TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease. van den Broek DHN; Chang YM; Elliott J; Jepson RE J Vet Intern Med; 2018 Jul; 32(4):1359-1371. PubMed ID: 29704284 [TBL] [Abstract][Full Text] [Related]
13. Serum fibroblast growth factor-23 concentrations in young and mature adult cats with chronic kidney disease. Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N J Feline Med Surg; 2022 Aug; 24(8):815-820. PubMed ID: 34431737 [TBL] [Abstract][Full Text] [Related]
14. Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate. Summers S; Quimby JM; Phillips RK; Stockman J; Isaiah A; Lidbury JA; Steiner JM; Suchodolski J J Vet Intern Med; 2020 Jan; 34(1):206-215. PubMed ID: 31693251 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil Gelatinase-Associated Lipocalin in Cats with Naturally Occurring Chronic Kidney Disease. Wang IC; Hsu WL; Wu PH; Yin HY; Tsai HJ; Lee YJ J Vet Intern Med; 2017 Jan; 31(1):102-108. PubMed ID: 28019047 [TBL] [Abstract][Full Text] [Related]
16. Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease. Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Am J Med Sci; 2014 May; 347(5):370-6. PubMed ID: 24051956 [TBL] [Abstract][Full Text] [Related]
17. Association between serum fibroblast growth factor-23 concentrations and blood calcium levels in chronic kidney disease cats with upper urolithiasis. Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N J Feline Med Surg; 2022 Dec; 24(12):1245-1252. PubMed ID: 35133180 [TBL] [Abstract][Full Text] [Related]
18. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152 [TBL] [Abstract][Full Text] [Related]
19. Relationship among serum creatinine, serum gastrin, calcium-phosphorus product, and uremic gastropathy in cats with chronic kidney disease. McLeland SM; Lunn KF; Duncan CG; Refsal KR; Quimby JM J Vet Intern Med; 2014; 28(3):827-37. PubMed ID: 24628683 [TBL] [Abstract][Full Text] [Related]
20. Detection of indoxyl sulfate levels in dogs and cats suffering from naturally occurring kidney diseases. Cheng FP; Hsieh MJ; Chou CC; Hsu WL; Lee YJ Vet J; 2015 Sep; 205(3):399-403. PubMed ID: 26118479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]